Effect of Erythromycin on Gastric Emptying Time of Low Birth Weight Babies

S S Mathai1, K S Bawa2, A Bhandari3

  • 1Associate Professor (Paediatrics), Armed Forces Medical College, Pune-411040.

Insights

Low dose erythromycin safely reduced gastric emptying time in preterm neonates. This intervention was effective in babies born after 34 weeks of gestation, with no observed side effects.

Area of Science:

  • Neonatal Medicine
  • Pharmacology
  • Gastroenterology

Background:

  • Investigating the impact of low-dose erythromycin on gastric emptying in low birth weight (LBW) neonates.
  • Assessing effects in neonates receiving breast milk, supplements, or human milk fortifier (HMF).

Purpose of the Study:

  • To evaluate the promotility effects of low-dose erythromycin on gastric emptying time (GET) in LBW neonates.
  • To determine safety and efficacy in different feeding regimens.

Main Methods:

  • Randomized control trial with 50 neonates receiving oral erythromycin (6mg/kg/day) or placebo for four days.
  • Gastric emptying time (GET) assessed via ultrasonography measuring antral cross-sectional area (ACSA).
  • Side effects and feeding type (breast milk, supplements, HMF) were monitored.

Main Results:

  • Erythromycin significantly decreased GET in the test group, particularly in preterm infants born after 34 weeks gestation.
  • The reduction in GET was observed with breast milk alone and with supplements, but not with HMF.
  • No adverse side effects were reported during the intervention.

Conclusions:

  • Low-dose erythromycin is a safe and effective method for reducing gastric emptying in preterm neonates.
  • The benefits were most pronounced in infants born after 34 weeks gestation within the first two weeks of life.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
645
Gastric Emptying01:16

Gastric Emptying

Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
4.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
313